Shuangni Yu
10PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 17, 2025
Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases.Xianlong Chen, Shanyue Sun, Jiapeng Zhao
|Jul 21, 2023
Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma.Heng Ma, Xianlong Chen, Shengwei Mo
|Jan 21, 2023
Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas.Liju Zong, Shengwei Mo, Zezheng Sun
|Mar 23, 2022
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study.Shuangni Yu, Zezheng Sun, Liju Zong
|Jan 27, 2022
Analysis of a novel immune checkpoint, Siglec-15, in pancreatic ductal adenocarcinoma.Xianlong Chen, Shengwei Mo, Yue Zhang
|Jan 17, 2022
PD-L1 and PD-L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules.Yue Zhang, Xianlong Chen, Shengwei Mo
Pageof 2
